Technology | Radiation Dose Management | September 07, 2017

Sapheneia/Scannerside Announces FDA Clearance for XR-29 Scannerside DoseCheck

Second-generation product designed to monitor radiation dose on CT scanners not equipped with DoseCheck functionality

September 7, 2017 β€” Sapheneia and Scannerside received U.S. Food and Drug Administration (FDA) 510(k) clearance to market their XR-29 DoseCheck solution. Scannerside DoseCheck is a third-party vendor-neutral computed tomography (CT) product that makes it affordable to update existing CT scanners and allows compliance with current Medical Imaging & Technology Alliance (MITA) radiation dose management standards.

The Sapheneia-Scannerside proprietary XR-29 DoseCheck solution is specifically designed to provide CT operators, prior to a scan, notifications and alerts of potential radiation doses over a predefined threshold. Scannerside DoseCheck is intended to be installed and used with CT scanners not equipped with these functionalities, independent of age, make and model. This newly introduced DoseCheck system encompasses a proprietary hardware and software solution with additional features that no other third-party solution can offer, according to the companies.

For more information: www.sapheneia.com, www.scannerside.com


Related Content

News | Computed Tomography (CT)

April 22, 2024 β€” A new study showed that a non-invasive imaging test can help identify patients with coronary artery ...

Home April 22, 2024
Home
Feature | Computed Tomography (CT) | By Alberto Morales, MD

Cardiac CT scans, recommended by the American College of Cardiology (ACC) and the American Heart Association (AHA) as ...

Home March 20, 2024
Home
News | Computed Tomography (CT)

February 20, 2024 β€” Ultrahigh-spatial-resolution photon-counting detector CT improved assessment of coronary artery ...

Home February 20, 2024
Home
News | Computed Tomography (CT)

HeartFlow is offering a free webinar based on a recent study that measured the ability of the of its roadmap analysis to ...

Home January 15, 2024
Home
News | Computed Tomography (CT)

December 19, 2023 β€” Siemens Healthineers announced the Food and Drug Administration (FDA) clearance of the Somatom Pro ...

Home December 19, 2023
Home
Feature | Computed Tomography (CT) | By Andrew Michalski, PhD and Rohit Sood MD, PhD

Coronary artery disease (CAD), also known as ischemic heart disease, is the most common heart disease with a prevalence ...

Home December 05, 2023
Home
News | Computed Tomography (CT)

October 26, 2023 β€” HeartFlow, Inc., a leader in non-invasive integrated artificial intelligence (AI) heart care ...

Home October 26, 2023
Home
News | Computed Tomography (CT)

October 13, 2023 β€” Arineta Cardiac Imaging is excited to announce the FDA 510(k) clearance of the SpotLight and ...

Home October 13, 2023
Home
News | Computed Tomography (CT)

September 29, 2023 β€”Nano-X Imaging, an innovative medical imaging technology company, today announced that HealthCCSng ...

Home September 29, 2023
Home
News | Computed Tomography (CT)

September 19, 2023 β€” An advanced CT test can identify individuals with stable angina at a reduced risk of three-year ...

Home September 19, 2023
Home
Subscribe Now